Lv11
20 积分 2024-08-09 加入
Abstract 4138847: Home Blood Pressure Reductions With Zilebesiran In Patients With Mild-To-Moderate Hypertension Are Consistent With Ambulatory And Office Blood Pressure Reductions In The KARDIA-1 Study
5小时前
求助中
DEFINING OPTIMAL ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD) RISK THRESHOLDS FOR CORONARY ARTERY CALCIUM (CAC) SCREENING: A COMPARATIVE ANALYSIS OF PREVENT™ AND POOLED COHORT EQUATIONS (PCE) IN PREDICTING CLINICALLY SIGNIFICANT CORONARY ARTERY CALCIUM
7小时前
求助中
Prevalence of chronic kidney disease in China: a cross-sectional survey
22天前
已完结
Prevalence and Trend of Biopsy-Proven IgA Nephropathy in China: A Systematic Review
22天前
已完结
Association of the Angiotensinogen Gene to Serum Angiotensinogen in Blacks and Whites
1个月前
已完结
Abstract 17395: Effect of ION904, an Antisense Inhibitor of Angiotensinogen Production: Results of Phase 1 and Phase 2 Pilot Studies
1个月前
已完结
Effects of blood pressure lowering on outcome incidence in hypertension
1个月前
已完结
Zilebesiran: A Promising Antihypertensive Therapy Inhibiting Angiotensinogen Synthesis
1个月前
已完结
Comparison of gelatin and low-molecular weight gelatin hydrolysate ingestion on hydroxyproline (Hyp), Pro-Hyp and Hyp-Gly concentrations in human blood
1个月前
已完结
Add-On Treatment With Zilebesiran for Inadequately Controlled Hypertension
2个月前
已完结
皖公网安备34019202002308
